Target Price | $109.80 |
Price | $75.61 |
Potential |
45.22%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target Haemonetics Corporation 2025 .
The average Haemonetics Corporation target price is $109.80.
This is
45.22%
register free of charge
$125.00
65.32%
register free of charge
$85.00
12.42%
register free of charge
|
|
A rating was issued by 11 analysts: 8 Analysts recommend Haemonetics Corporation to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Haemonetics Corporation stock has an average upside potential 2025 of
45.22%
register free of charge
|
Mar '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 1.31 | 1.40 |
12.01% | 6.71% | |
EBITDA Margin | 23.33% | 30.06% |
4.64% | 28.87% | |
Net Margin | 8.95% | 12.56% |
8.73% | 40.37% |
10 Analysts have issued a sales forecast Haemonetics Corporation 2025 . The average Haemonetics Corporation sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Haemonetics Corporation EBITDA forecast 2025. The average Haemonetics Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Haemonetics Corporation Analysts have issued a net profit forecast 2025. The average Haemonetics Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 2.29 | 3.43 |
2.23% | 49.78% | |
P/E | 22.31 | |
EV/Sales | 3.43 |
5 Analysts have issued a Haemonetics Corporation forecast for earnings per share. The average Haemonetics Corporation <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Haemonetics Corporation stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Haemonetics Corporation...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.